Phase II study of 4′-iodo-4′-deoxydoxorubicin in non-resectable non-small-cell lung cancer

[1]  J. Walling.  Chemotherapy for advanced non-small-cell lung cancer. , 1994, Respiratory medicine.

[2]  J. Sørensen.  Treatment of non-small cell lung cancer: new cytostatic agents , 1993 .

[3]  F. Cavalli,et al.  Phase II studies of 4'-iodo-4'-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancers. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  A. Luini,et al.  Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancer. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  U. Gatzemeier,et al.  Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society. , 1990, Onkologie.

[6]  G. Bonadonna,et al.  Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials. , 1990, Journal of the National Cancer Institute.

[7]  A. Rossof,et al.  Phase II trial of 4′ deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma , 1990, Investigational new drugs.

[8]  R. Arriagada,et al.  Phase II study of pirarubicin in advanced non-small cell lung cancer. , 1989, European Journal of Cancer and Clinical Oncology.

[9]  C. Mountain,et al.  A new international staging system for lung cancer. , 1987, Chest.

[10]  B. Conley,et al.  Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer. , 1987, Cancer treatment reports.

[11]  S. Penco,et al.  Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin. , 1987, Cancer research.

[12]  R. Simon,et al.  Confidence intervals for reporting results of clinical trials. , 1986, Annals of internal medicine.

[13]  C. Mountain.  The new International Staging System for Lung Cancer. , 1986, The Surgical clinics of North America.

[14]  F. Cavalli,et al.  Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer. , 1985, Cancer treatment reports.

[15]  J. Sørensen.  Treatment of non-small cell lung cancer: new cytostatic agents. , 1993, Lung Cancer.

[16]  J. Bergh,et al.  Current status of epirubicin (Farmorubicin) in the treatment of solid tumours. , 1990, Acta oncologica.

[17]  K. Propert,et al.  Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B Trial. , 1988, Medical and pediatric oncology.

[18]  M. Rozencweig,et al.  European studies with adriamycin (NSC 123127) in lung cancer , 1975 .